InvestorsHub Logo
Followers 116
Posts 1882
Boards Moderated 0
Alias Born 11/22/2017

Re: eagle8 post# 242039

Tuesday, 09/03/2019 9:48:39 AM

Tuesday, September 03, 2019 9:48:39 AM

Post# of 709712

It's a lot of information about opposition by Dr. Martin van den Bent concerns immunotherapy. Martin van den Bent is the highest 'boss' in Holland and Europe in the field of brain tumors.



hmm..... Martin van den Bent is co-author of this publication:

"First results on the DCVax phase III trial: raising more questions than providing answers."

Wolfgang Wick and Martin J van den Bent

Neuro Oncol. 2018 Sep 3;20(10):1283-1284. doi: 10.1093/neuonc/noy125.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120355/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News